Clinical and research tests for C3810138 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 25

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Arrythmogenic Cardiomyopathy Panel Health in Code Spain	53	17	C Sequence analysis of the entire coding region
CTNNA3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoNeuro Panel Centogene AG - the Rare Disease Company Germany	1886	1858	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Intellectual Disability Panel Centogene AG - the Rare Disease Company Germany	777	770	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
CentoCardio Panel Centogene AG - the Rare Disease Company Germany	289	275	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Arrhythmogenic right ventricular dysplasia, familial, 13, 615616, Autosomal dominant; ARVD13 (Familial isolated arrhythmogenic right ventricular dysplasia) (CTNNA3 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Pan Cardiomyopathy Panel PreventionGenetics, part of Exact Sciences United States	113	106	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Comprehensive Cardiology Panel PreventionGenetics, part of Exact Sciences United States	223	198	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Comprehensive Cardiac Arrhythmia Panel PreventionGenetics, part of Exact Sciences United States	77	64	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)/Dysplasia Panel PreventionGenetics, part of Exact Sciences United States	17	17	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Arrhythmogenic right ventricular dysplasia 13 (ARVD, sequence analysis of CTNNA3 gene) CGC Genetics Unilabs Portugal	1	1	C Sequence analysis of the entire coding region
Arrhythmia panel. NGS panel of 55 genes. Genologica Medica Spain	128	55	C Sequence analysis of the entire coding region
Arrhythmogenic right ventricular dysplasia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada	10	9	C Sequence analysis of the entire coding region
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States	450	128	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Arrhythmogenic Right Ventricular Cardiomyopathy NGS Panel Fulgent Genetics United States	118	46	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Cardiology Genetic Panel (Full) , Panel Massive Sequencing (NGS) 96 Genes Reference Laboratory Genetics Spain	119	95	C Sequence analysis of the entire coding region
Ventricular Arrhythmia and Sudden Cardiac Death , Panel Massive Sequencing (NGS) 48 Genes Reference Laboratory Genetics Spain	81	48	C Sequence analysis of the entire coding region
Arrhythmogenic Right Ventricular Dysplasia/ Cardiomyopathy Asper Biogene Asper Biogene LLC Estonia	22	14	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CTNNA3 Gene Sequencing and Deletion/Duplication Analysis DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CTNNA3 Single Gene Fulgent Genetics United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 25

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.